SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-079964
Filing Date
2023-03-27
Accepted
2023-03-27 09:59:55
Documents
14
Period of Report
2023-03-23
Items
Item 1.03: Bankruptcy or Receivership
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467120d8k.htm   iXBRL 8-K 34404
2 EX-99.1 d467120dex991.htm EX-99.1 7744
6 GRAPHIC g467120g0327065712313.jpg GRAPHIC 2916
  Complete submission text file 0001193125-23-079964.txt   178781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cdak-20230323.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20230323_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20230323_pre.xml EX-101.PRE 11711
8 EXTRACTED XBRL INSTANCE DOCUMENT d467120d8k_htm.xml XML 3475
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39615 | Film No.: 23761751
SIC: 2836 Biological Products, (No Diagnostic Substances)